AUDIT OF SELECTED PHARMACEUTICAL MANUFACTURERS THAT ARE STAKEHOLDERS IN HYPERLIPIDEMIA/ATHEROSCLEROSIS AND OTHER CARDIOVASCULAR INDICATIONS
ABBOTT LABORATORIES
AKZO NOBEL/ORGANON
AMERICAN HOME PRODUCTS
ASTRAZENECA
AVENTIS
BASF/KNOLL
BAYER
BOEHRINGER INGELHEIM
BRISTOL-MYERS SQUIBB
DUPONT
ELI LILLY
FOREST
GLAXO WELLCOME
JOHNSON & JOHNSON
MERCK & CO.
MONSANTO/SEARLE
NOVARTIS
PFIZER
PHARMACIA CORP.
PROCTER & GAMBLE
ROCHE
SANOFI-SYNTHÉLABO
SCHERING AG/BERLEX
SCHERING-PLOUGH
SMITHKLINE BEECHAM
WARNER-LAMBERT